UIM
BMY icon

USS Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

USS Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6M Buy
392,285
+9,391
+2% +$539K 0.08% 149
2026
Q1 		$23.2M Buy
382,894
+20,383
+6% +$1.19M 0.09% 119
2025
Q4 		$19.6M Buy
362,511
+6,259
+2% +$301K 0.09% 129
2025
Q3 		$16.1M Hold
356,252
– – 0.07% 150
2025
Q2 		$16.5M Buy
356,252
+2,542
+0.7% +$125K 0.1% 134
2025
Q1 		$21.6M Sell
353,710
-126
-0% -$7.34K 0.16% 96
2024
Q4 		$20M Sell
353,836
-46,833
-12% -$2.62M 0.14% 120
2024
Q3 		$20.7M Buy
400,669
+13,898
+4% +$652K 0.15% 117
2024
Q2 		$16.1M Buy
386,771
+10,135
+3% +$453K 0.13% 131
2024
Q1 		$20.4M Buy
376,636
+19,675
+6% +$1M 0.17% 104
2023
Q4 		$18.3M Sell
356,961
-77,621
-18% -$4.07M 0.16% 107
2023
Q3 		$25.2M Buy
434,582
+14,522
+3% +$890K 0.27% 72
2023
Q2 		$26.9M Buy
420,060
+5,032
+1% +$337K 0.32% 67
2023
Q1 		$28.8M Buy
415,028
+9,249
+2% +$652K 0.39% 52
2022
Q4 		$29.2M Sell
405,779
-114,300
-22% -$8.62M 0.41% 49
2022
Q3 		$37M Sell
520,079
-164,208
-24% -$11.9M 0.54% 30
2022
Q2 		$52.7M Sell
684,287
-23,990
-3% -$1.83M 0.53% 33
2022
Q1 		$51.7M Buy
708,277
+27,469
+4% +$1.84M 0.42% 46
2021
Q4 		$42.5M Hold
680,808
– – 0.32% 72
2021
Q3 		$40.3M Buy
680,808
+126,679
+23% +$8.34M 0.34% 66
2021
Q2 		$37M Hold
554,129
– – 0.29% 78
2021
Q1 		$35M Hold
554,129
– – 0.3% 79
2020
Q4 		$34.4M Buy
554,129
+13,200
+2% +$812K 0.31% 76
2020
Q3 		$32.6M Buy
540,929
+7,065
+1% +$425K 0.31% 79
2020
Q2 		$31.4M Buy
533,864
+201,427
+61% +$12M 0.33% 73
2020
Q1 		$18.5M Buy
332,437
+310,137
+1,391% +$19M 0.25% 92
2019
Q4 		$1.43M Buy
+22,300
New +$1.28M 0.01% 215

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

USS Investment Management's BMY Position: Q2 2026 in Review

USS Investment Management increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, buying an estimated $539K and bringing the position to 392,285 shares worth $22.6M. The position accounts for 0.08% of the portfolio, ranked #149.

USS Investment Management first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $52.7M in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • USS Investment Management held 392,285 shares of Bristol-Myers Squibb worth $22.6M as of Q2 2026.
  • USS Investment Management bought 9,391 Bristol-Myers Squibb shares in Q2 2026, an estimated $539K.
  • Bristol-Myers Squibb made up 0.08% of USS Investment Management's portfolio in Q2 2026, its #149 holding.
  • USS Investment Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • USS Investment Management's Bristol-Myers Squibb position peaked at $52.7M in Q2 2022.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.